Production of Human α‐1‐Antitrypsin from Transgenic Rice Cell Culture in a Membrane Bioreactor

Transgenic plant cell cultures offer a number of advantages over alternative host expression systems, but so far relatively low product concentrations have been achieved. In this study, transgenic rice cells are used in a two‐compartment membrane bioreactor (CELLine 350, Integra Biosciences) for the production of recombinant α‐1‐antitrypsin (rAAT). Expression of rAAT is controlled by the rice α‐amylase (RAmy3D) promoter, which is induced in the absence of sugar. The extracellular product is retained in the bioreactorapos;s relatively small cell compartment, thereby increasing product concentration. Due to the packed nature of the cell aggregates in the cell compartment, a clarified product solution can be withdrawn from the bioreactor. Active rAAT reached levels of 100–247 mg/L (4–10% of the total extracellular protein) in the cell compartment at 5–6 days postinduction, and multiple inductions of the RAmy3D promoter were demonstrated.

[1]  N. Emans,et al.  Towards molecular farming in the future: using plant‐cell‐suspension cultures as bioreactors , 1999, Biotechnology and applied biochemistry.

[2]  U Marx,et al.  Membrane-based cell culture systems--an alternative to in vivo production of monoclonal antibodies. , 1999, Developments in biological standardization.

[3]  Ramakrishnan,et al.  Monitoring biomass in root culture systems. , 1999, Biotechnology and bioengineering.

[4]  C. Goudar,et al.  Experimental and Theoretical Analysis of Tubular Membrane Aeration for Mammalian Cell Bioreactors , 2008, Biotechnology progress (Print).

[5]  R. Rodriguez,et al.  Production of functional human α1-antitrypsin by plant cell culture , 1999, Applied Microbiology and Biotechnology.

[6]  Liying Wu,et al.  Expression of functional recombinant human lysozyme in transgenic rice cell culture , 2002, Transgenic Research.

[7]  Leroy Hood,et al.  Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. , 2004, Journal of proteome research.

[8]  J. Goergen,et al.  Determination of growth and lysis kinetics in plant cell suspension cultures from the measurement of esterase release. , 1999, Biotechnology and bioengineering.

[9]  Y. Jang,et al.  High level of expression of recombinant human granulocyte-macrophage colony stimulating factor in transgenic rice cell suspension culture. , 2003, Biotechnology and bioengineering.

[10]  Karen A. McDonald,et al.  Characterization of plant suspension cultures using the focused beam reflectance technique , 2001, Biotechnology Letters.

[11]  Y. Jang,et al.  Production of biologically active hG-CSF by transgenic plant cell suspension culture , 2002 .

[12]  R. Rodriguez,et al.  Metabolic regulation of α-amylase gene expression in transgenic cell cultures of rice (Oryza sativa L.) , 1993, Plant Molecular Biology.

[13]  J. Draper,et al.  Secretion of a functional single-chain Fv protein in transgenic tobacco plants and cell suspension cultures , 1993, Plant Molecular Biology.

[14]  P. Ohlsson,et al.  Structural insights into serpin—protease complexes reveal the inhibitory mechanism of serpins , 1997, Nature Structural Biology.

[15]  Rainer Fischer,et al.  Plant cell cultures for the production of recombinant proteins , 2004, Nature Biotechnology.

[16]  M. Brantly,et al.  Clinical features and molecular characteristics of alpha 1-antitrypsin deficiency. , 1994, Annals of allergy.

[17]  J. Travis,et al.  Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. , 1980, The Journal of biological chemistry.

[18]  S. Schillberg,et al.  Molecular Farming of Medicines: A Field of Growing Promise , 2001 .

[19]  jae-hwa Lee,et al.  Production and secretion of biologically active human granulocyte-macrophage colony stimulating factor in transgenic tomato suspension cultures , 2003, Biotechnology Letters.

[20]  E T MacKenzie,et al.  A soluble transforming growth factor-beta (TGF-beta ) type I receptor mimics TGF-beta responses. , 2001, The Journal of biological chemistry.

[21]  Y. Jang,et al.  Secretory production of hGM-CSF with a high specific biological activity by transgenic plant cell suspension culture , 2003 .

[22]  P. Doran,et al.  Foreign protein production in plant tissue cultures. , 2000, Current opinion in biotechnology.

[23]  Karen A. McDonald,et al.  Bioreactor Production of Human α1‐Antitrypsin Using Metabolically Regulated Plant Cell Cultures , 2002 .

[24]  E. Cocking,et al.  Protoplast culture of rice (Oryza sativa L.) using media solidified with agarose , 1986 .

[25]  Alain Buisson,et al.  A Soluble Transforming Growth Factor-β (TGF-β) Type I Receptor Mimics TGF-β Responses* , 2001, The Journal of Biological Chemistry.

[26]  J. M. Chong,et al.  Efficient laboratory-scale production of monoclonal antibodies using membrane-based high-density cell culture technology. , 1999, Journal of immunological methods.

[27]  Somen Nandi,et al.  Expression and Purification of Functional Human α‐1‐Antitrypsin from Cultured Plant Cells , 2001, Biotechnology progress.

[28]  P. Doran,et al.  Design of Mixing Systems for Plant Cell Suspensions in Stirred Reactors , 1999, Biotechnology progress.

[29]  P. Elzen,et al.  Production of Correctly Processed Human Serum Albumin in Transgenic Plants , 1990, Bio/Technology.

[30]  P. Doran,et al.  Effect of bacitracin on growth and monoclonal antibody production by tobacco hairy roots and cell suspensions , 1999 .

[31]  R. Reeves,et al.  Secretion of biologically active human interleukin-2 and interleukin-4 from genetically modified tobacco cells in suspension culture. , 1998, Protein expression and purification.

[32]  R. Twyman,et al.  Practical considerations for pharmaceutical antibody production in different crop systems , 2002, Molecular Breeding.

[33]  G. Payne,et al.  Bioreactor considerations for secondary metabolite production from plant cell tissue culture: Indole alkaloids from Catharanthus roseus , 1988, Biotechnology and bioengineering.

[34]  H. Caram,et al.  Optimal Design of the Tubular Microporous Membrane Aerator for Shear‐Sensitive Cell Cultures , 1992, Biotechnology progress.

[35]  P. Doran,et al.  Production of monoclonal antibodies by tobacco hairy roots. , 1997, Biotechnology and bioengineering.

[36]  Alain Buisson,et al.  A soluble TGF-beta type-1 receptor mimics TGF-beta responses , 2001 .

[37]  M. Terashima,et al.  Effect of osmotic pressure on human α1-antitrypsin production by plant cell culture , 1999 .

[38]  R Fischer,et al.  Affinity-purification of a TMV-specific recombinant full-size antibody from a transgenic tobacco suspension culture. , 1999, Journal of immunological methods.

[39]  D K Glencross,et al.  Manufacture of pure monoclonal antibodies by heterogeneous culture without downstream purification. , 2001, BioTechniques.

[40]  Victoria Boyd,et al.  Dialysis-based bioreactor systems for the production of monoclonal antibodies--alternatives to ascites production in mice. , 2002, Journal of immunological methods.

[41]  A. P. Jackman,et al.  A Cyclical Semicontinuous Process for Production of Human α1‐Antitrypsin Using Metabolically Induced Plant Cell Suspension Cultures , 2008, Biotechnology progress.

[42]  R M Ben Aim,et al.  Membrane bioreactors for wastewater treatment and reuse: a success story. , 2003, Water science and technology : a journal of the International Association on Water Pollution Research.

[43]  R. Reeves,et al.  Production and characterization of biologically active human GM-CSF secreted by genetically modified plant cells. , 2000, Protein expression and purification.